Package 60687-299-25

{"route": ["ORAL"], "spl_id": "31555f81-410c-9a69-e063-6394a90ab705", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "unii": ["304NUG5GF4"], "rxcui": ["311204"], "spl_set_id": ["e564067e-e469-4c51-9076-75f89f5c5cdf"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-299-25)  / 1 CAPSULE in 1 BLISTER PACK (60687-299-95)", "package_ndc": "60687-299-25", "marketing_start_date": "20170502"}], "brand_name": "Itraconazole", "product_id": "60687-299_31555f81-410c-9a69-e063-6394a90ab705", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "60687-299", "generic_name": "Itraconazole", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Itraconazole", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "100 mg/1"}], "application_number": "ANDA205080", "marketing_category": "ANDA", "marketing_start_date": "20170502", "listing_expiration_date": "20261231"}